Clinical Trials Browser

Phase 3 × Prostatic Neoplasms × Suramin × Clear all

NCT00002723 2013-02-28

Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00002881 2010-11-09

Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms